Is CHCR or MRK a better dividend investment in 2026?

CHCR currently yields 16299974.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CHCR offers higher current income.

What is the dividend yield difference between CHCR and MRK?

CHCR has a forward dividend yield of 16299974.00% ($16.30/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 16299971.24 percentage points.

Home › Compare › CHCR vs MRK

CHCR vs MRK: Dividend Comparison 2026

CHCR yields 16299974.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHCR wins by $6.304323781898378e+48M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHCR

● Live price

16299974.00%

Share price

$0.00

Annual div

$16.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$6.304323781898378e+48M

Annual income

$6,304,247,699,510,647,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full CHCR calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CHCR vs MRK

📍 CHCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHCR	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHCR + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHCR pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHCR

Annual income on $10K today (after 15% tax)

$1,385,497,790.00/yr

After 10yr DRIP, annual income (after tax)

$5,358,610,544,584,050,400,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CHCR beats the other by $5,358,610,544,584,050,400,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHCR + MRK for your $10,000?

CHCR: 50%MRK: 50%

100% MRK50/50100% CHCR

Portfolio after 10yr

$3.152161890949189e+48M

Annual income

$3,152,123,849,755,324,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CHCR

No analyst data

Altman Z

-71.4

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHCR buys

MRK buys

No recent congressional trades found for CHCR or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHCRMRK

Forward yield	16299974.00% ✓	2.76%
Annual dividend / share	$16.30 ✓	$3.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$6.304323781898378e+48M	$56.8K ✓
Annual income after 10y	$6,304,247,699,510,647,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$6.304318804493443e+48M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CHCR vs MRK ($10,000, DRIP)

Year	CHCR Portfolio	CHCR Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$1,630,008,100	$1,629,997,400.00	$11,206	$366.19	+$1630.00M → CHCR
2	$248,310,993,172,119	$248,309,249,063,452.47	$12,650	$502.35	+$248310993.16M → CHCR
3	$35,352,372,711,888,600,000	$35,352,107,019,125,903,000.00	$14,407	$694.19	+$35352372711888.59M → CHCR
4	$4,703,895,210,347,744,700,000,000	$4,703,857,383,308,944,000,000,000.00	$16,585	$967.82	+$4703895210347744256.00M → CHCR
5	$584,942,498,970,756,060,000,000,000,000	$584,937,465,802,880,900,000,000,000,000.00	$19,342	$1,363.89	+$5.849424989707561e+23M → CHCR
6	$67,980,632,016,017,940,000,000,000,000,000,000	$67,980,006,127,544,040,000,000,000,000,000,000.00	$22,913	$1,947.19	+$6.798063201601794e+28M → CHCR
7	$7,383,694,540,484,102,000,000,000,000,000,000,000,000	$7,383,621,801,207,846,000,000,000,000,000,000,000,000.00	$27,662	$2,823.89	+$7.383694540484103e+33M → CHCR
8	$749,512,305,709,058,000,000,000,000,000,000,000,000,000,000	$749,504,405,155,899,700,000,000,000,000,000,000,000,000,000.00	$34,159	$4,173.35	+$7.49512305709058e+38M → CHCR
9	$71,105,035,262,902,380,000,000,000,000,000,000,000,000,000,000,000	$71,104,233,284,735,270,000,000,000,000,000,000,000,000,000,000,000.00	$43,337	$6,308.80	+$7.110503526290238e+43M → CHCR
10	$6,304,323,781,898,378,000,000,000,000,000,000,000,000,000,000,000,000,000	$6,304,247,699,510,647,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$6.304323781898378e+48M → CHCR

CHCR vs MRK: Complete Analysis 2026

CHCR — Stock

Advanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.

Full CHCR Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CHCR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHCR vs SCHD CHCR vs JEPI CHCR vs O CHCR vs KO CHCR vs MAIN CHCR vs JNJ CHCR vs ABBV CHCR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.